HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Alessandro Stefani Christian Casali Uliano Morandi Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stefani, A. Articles by Morandi, U. Search for Related Content PubMed PubMed Citation Articles by Stefani, A. Articles by Morandi, U. Related Collections Pleura

Eur J Cardiothorac Surg 2006;30:827-832
© 2006 Elsevier Science NL

Talc poudrage versus talc slurry in the treatment of malignant pleural effusion.

A prospective comparative study

Division of Thoracic Surgery, Department of General Surgery and Surgical Specialities, University of Modena and Reggio Emilia, Italy

Received 2 August 2006; received in revised form 29 September 2006; accepted 3 October 2006.

^_* Corresponding author. Address: Divisione di Chirurgia Toracica, Università di Modena e Reggio Emilia, Largo del Pozzo 71, 41100 Modena, Italy. Tel.: +39 059 4222257; fax: +39 059 360159. (Email: morandi.uliano{at}unimore.it).

Objective: The aim of this study was to investigate the effectiveness, safety and appropriate mode of administration of intrapleural talc for pleurodesis, in the treatment of malignant pleural effusion (MPE). Methods: Prospective not randomized trial was conducted to compare thoracoscopic talc poudrage (TP) with tube thoracostomy and talc slurry (TS) for the local control of malignant pleural effusion. Both procedures were previously standardized; 6 g of talc was administered for each procedure. Only the patients with lung re-expansion after drainage entered the study. Patients at high risk for general anaesthesia, poor general conditions and short life-expectancy received talc slurry through a chest tube, at the bedside. All the other patients underwent videothoracoscopic talc poudrage, with a pneumatic atomizer, under general anaesthesia. Morbidity, 30-day freedom from recurrence and long-term results were assessed and the two groups were compared. Results: One hundred and nine patients entered the study (72 TP, 37 TS). Sixty-three patients in the TP group (87.5%) and 27 in the TS group (73%) had an immediate successful pleurodesis (p = 0.049); 53 patients (88.3%) and 16 patients (69.6%) had a successful pleurodesis 90 days after the procedure; 59 patients (81.9%) and 23 patients (62.2%), respectively, had a life-long pleural symphysis (p = 0.023). Adverse effects were generally mild: chest pain (36.1% in TP patients, 48.6% in TS patients) and fever (38.8% and 35.1%, respectively) were the more common but the difference was not significant between the two groups. We observed neither acute respiratory failure nor mortality due to the procedure. Conclusions: Our study confirms that intrapleural talc carries good results in the treatment of malignant pleural effusion. TP was significantly more effective than TS; both methods were safe but TS had a higher incidence of thoracic pain during the procedure. Talc pleurodesis should be offered to every patient with MPE, apart from terminally ill ones, provided that a satisfying lung re-expansion has been achieved. TP should be performed whenever possible; otherwise, a slurry bedside procedure will be worthwhile, even in patients with low performance status (PS), though poorer results have to be expected. A careful selection is essential to define the proper technique.

Key Words: Pleural effusion • Cancer • Talc

This article has been cited by other articles:

				R. M. Terra, J. J. M. Junqueira, L. R. Teixeira, F. S. Vargas, P. M. Pego-Fernandes, and F. B. Jatene Is Full Postpleurodesis Lung Expansion a Determinant of a Successful Outcome After Talc Pleurodesis? Chest, August 1, 2009; 136(2): 361 - 368. [Abstract] [Full Text] [PDF]

				J. A. Burgers, P. W. A. Kunst, M. G. J. Koolen, L. N. A. Willems, J. S. Burgers, and M. van den Heuvel Pleural drainage and pleurodesis: implementation of guidelines in four hospitals Eur. Respir. J., November 1, 2008; 32(5): 1321 - 1327. [Abstract] [Full Text] [PDF]

				J. E. Heffner and J. S. Klein Recent Advances in the Diagnosis and Management of Malignant Pleural Effusions Mayo Clin. Proc., February 1, 2008; 83(2): 235 - 250. [Abstract] [Full Text] [PDF]

				S. Margaritora, A. Cesario, M. L. Vita, and P. Granone Single versus multiple access video-assisted thoracic surgery in the treatment of malignant pleural effusion Eur. J. Cardiothorac. Surg., August 1, 2007; 32(2): 397 - 397. [Full Text] [PDF]

				T. F. Molnar and R. Rami-Porta Some reflections on talc poudrage Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1147 - 1147. [Full Text] [PDF]